The search results provided include detailed studies on recombinant rat proteins such as:
None of these sources mention "SM-11044-binding protein," nor do any other entries in the provided materials.
The term "SM-11044" does not correspond to established nomenclature in protein databases (e.g., UniProt, NCBI) or peer-reviewed literature. Possible explanations include:
Typographical error: The compound name may be misspelled (e.g., "SM-11044" vs. "SM-1104" or "SME-11044").
Proprietary code: "SM-11044" could represent an internal identifier from unpublished research or a commercial entity not yet disclosed publicly.
Species specificity: The protein might be specific to a non-rat model or a hypothetical construct not yet characterized.
While no data exists for "SM-11044-binding protein," the search results highlight critical features of recombinant rat proteins that could guide future research:
To resolve the ambiguity surrounding "SM-11044-binding protein," the following steps are advised:
Verify nomenclature: Cross-reference with databases like UniProt, GenBank, or the Rat Genome Database.
Explore patent literature: Proprietary compounds may be documented in patent filings.
Consult recent publications: Focus on post-2025 studies, as the provided search results extend only to early 2025.
SM-11044-binding protein (SMBP) appears in studies related to gene expression regulation, showing a Z ratio of 1.69 in HuR-regulated gene expression analysis . While complete characterization in rat models remains ongoing, it shares functional similarities with other binding proteins that regulate RNA metabolism and cellular pathways. Like many RNA-binding proteins, it likely participates in fundamental cellular processes such as RNA processing, transport, or translation regulation . Research indicates that binding proteins similar to SMBP can influence gene expression profiles in various cellular contexts, particularly in stress response pathways.
Methodological approach: To characterize SMBP function in rat models, researchers typically employ RNA immunoprecipitation followed by sequencing (RIP-seq) to identify RNA targets, coupled with loss-of-function and gain-of-function studies to assess phenotypic consequences. Multiple tissue types should be examined to determine expression patterns and tissue-specific functions.
When designing experiments with recombinant rat SM-11044-binding protein, researchers must consider its structural characteristics. Like other binding proteins, SMBP likely contains specific binding domains that influence its interaction with SM-11044 and other potential binding partners. The structure may be similar to other characterized proteins like p110nrb, which contains two conserved RNP motifs in its carboxyl terminal portion , or share elements with proteins like ROBO1, which contains multiple domains including Ig-like domains and fibronectin type III domains .
Methodological approach: Structure-based experimental design should begin with in silico modeling based on homologous proteins, followed by empirical structure determination using X-ray crystallography, NMR, or cryo-EM. Domain truncation experiments and site-directed mutagenesis studies should target predicted functional regions to verify their importance in binding activity.
The identification of key domains and binding sites requires a systematic approach combining computational and experimental methods:
| Method | Application | Experimental Output |
|---|---|---|
| Sequence alignment | Identification of conserved domains | Homology mapping to known binding proteins |
| Deletion mapping | Domain function verification | Activity of truncated protein constructs |
| Site-directed mutagenesis | Specific residue function | Binding affinity changes after mutation |
| Surface plasmon resonance | Binding kinetics measurement | Association/dissociation rates (kon/koff) |
| Cross-linking mass spectrometry | Binding interface identification | Direct contact points between protein and ligand |
Methodological approach: Begin with bioinformatic analysis to identify potential binding domains based on sequence homology with characterized proteins. Generate a series of truncated constructs to experimentally verify domain function. Follow with alanine scanning mutagenesis of predicted binding interfaces, assessing mutant proteins for altered binding capabilities.
The choice of expression system significantly impacts the yield and functionality of recombinant rat SM-11044-binding protein:
Methodological approach: For initial characterization, express the protein in E. coli with affinity tags for purification. If functionality is compromised, move to insect cell systems like those used for p110nrb expression . For studies requiring native-like post-translational modifications, mammalian expression systems like CHO or BHK cells would be more appropriate, following approaches used for other complex recombinant proteins .
A multi-step purification strategy is required to obtain high-purity recombinant rat SM-11044-binding protein:
Initial capture: Affinity chromatography using a fusion tag (His, GST, or Fc) similar to the approach used for p110nrb purification with GST fusion
Intermediate purification: Ion exchange chromatography based on the protein's charge properties
Polishing: Size exclusion chromatography to remove aggregates and achieve homogeneity
Quality control: Assess purity by SDS-PAGE and mass spectrometry
Methodological approach: Design a construct with an N-terminal affinity tag separated from the protein by a protease cleavage site. After initial affinity purification, remove the tag and perform subsequent purification steps. For structural studies, verify protein homogeneity by dynamic light scattering and test crystallization conditions at various protein concentrations.
Post-translational modifications (PTMs) significantly influence protein function and must be considered when characterizing recombinant rat SM-11044-binding protein:
Methodological approach: Compare protein expressed in different systems (e.g., E. coli vs. mammalian cells) to assess functional differences. Use mass spectrometry to map PTMs. Consider site-directed mutagenesis of potential modification sites to assess their functional importance. Remember that glycosylation patterns can mask epitopes and influence protein-protein interactions .
Several functional assays can determine the biological activity of recombinant rat SM-11044-binding protein:
Methodological approach: First establish direct binding assays to verify interaction with SM-11044. Follow with cell-based assays to assess functional consequences, similar to approaches used to study effects of RNA-binding proteins on gene expression . Design experiments to test specific hypotheses about the protein's role in cellular pathways.
RNA-sequencing approaches can be powerful tools for studying the impact of SM-11044-binding protein on gene expression:
CLIP-seq (Cross-linking immunoprecipitation followed by sequencing): Identifies direct RNA binding sites
RNA-seq after knockdown/overexpression: Reveals genes regulated by the protein
Ribosome profiling: Detects effects on translation efficiency
Nascent RNA sequencing: Distinguishes transcriptional from post-transcriptional effects
Methodological approach: Design experiments similar to those used to study multifunctional RNA-binding proteins that influence both mRNA abundance and translation . Begin with differential expression analysis comparing control and SM-11044-binding protein knockdown/overexpression conditions. Follow with CLIP-seq to identify direct binding targets. Integrate datasets to distinguish direct from indirect effects.
Several biophysical techniques offer complementary information on binding kinetics:
| Technique | Parameters Measured | Advantages | Limitations |
|---|---|---|---|
| Surface Plasmon Resonance | kon, koff, KD | Real-time measurement | Requires immobilization |
| Isothermal Titration Calorimetry | KD, ΔH, ΔS, ΔG | Label-free, thermodynamic parameters | Requires larger sample amounts |
| Microscale Thermophoresis | KD | Low sample consumption | Requires fluorescent labeling |
| Bio-Layer Interferometry | kon, koff, KD | Real-time, minimal sample preparation | Lower sensitivity than SPR |
Methodological approach: Begin with SPR to determine basic binding parameters, using the recombinant protein immobilized on a sensor chip and SM-11044 as the analyte in solution. Verify results with complementary techniques like ITC to obtain thermodynamic parameters. For complex binding mechanisms, consider kinetic modeling to fit experimental data.
Glycosylation can profoundly impact protein function and stability. Research on other proteins indicates:
N-linked glycosylation enhances protein stability and solubility
Different glycoforms can affect binding properties and receptor recognition
Glycosylation may mask epitopes, altering immunogenicity and protein-protein interactions
Expression system choice significantly influences glycosylation patterns
Methodological approach: Express the protein in different systems (bacterial, insect, and mammalian cells) to generate variants with different glycosylation patterns. Use glycosidase treatments to remove specific glycans. Compare stability, binding properties, and functional activity among these variants. Use mass spectrometry to characterize glycan structures and sites.
When facing expression and solubility challenges:
| Challenge | Strategy | Implementation Approach |
|---|---|---|
| Low expression | Codon optimization | Adapt codons to expression host preferences |
| Insolubility | Fusion partners | Add solubility-enhancing tags (MBP, SUMO, TRX) |
| Incorrect folding | Chaperone co-expression | Co-express molecular chaperones in host cells |
| Proteolytic degradation | Protease inhibitors | Include appropriate inhibitor cocktails |
| Aggregation | Buffer optimization | Screen buffer conditions with thermal shift assays |
Methodological approach: Begin with systematic optimization of expression conditions (temperature, induction time, media composition). If solubility remains problematic, test different fusion tags and expression hosts. For difficult proteins, consider cell-free expression systems or refolding from inclusion bodies.
CRISPR-Cas9 technology offers powerful approaches for studying protein function in vivo:
Complete knockout: Assess the phenotypic consequences of protein absence
Domain-specific mutations: Investigate structure-function relationships
Endogenous tagging: Study localization and interactions under physiological conditions
Conditional knockout: Control expression temporally to study developmental roles
Methodological approach: Design guide RNAs targeting either the entire gene (for knockout) or specific domains (for precise modifications). Include appropriate selection markers and screening strategies. Validate edits by sequencing and confirm functional consequences using protein expression analysis, RNA-seq, and phenotypic assays relevant to the protein's suspected function.
Proper storage is critical for maintaining protein activity:
Methodological approach: After purification, concentrate the protein to an appropriate level (typically 1-10 mg/mL). For carrier-free preparations, special care must be taken, as the absence of carrier proteins like BSA may affect stability . Divide into small aliquots and flash-freeze in liquid nitrogen before transferring to -80°C storage. Reconstitute lyophilized protein in sterile PBS or another appropriate buffer at approximately 100 μg/mL .
Distinguishing specific from non-specific binding requires rigorous experimental design:
Competitive binding assays: Include excess unlabeled ligand to compete with labeled ligand
Negative controls: Test binding to irrelevant proteins of similar structure
Concentration dependence: Specific binding typically saturates while non-specific binding often increases linearly
Mutational analysis: Mutations in binding interfaces should reduce specific but not non-specific binding
Kinetic analysis: Specific binding typically shows defined kinetic parameters
Methodological approach: Design binding assays that include appropriate positive and negative controls. Use multiple binding assay formats (e.g., SPR, ITC, fluorescence polarization) to cross-validate results. Include displacement experiments with structurally related compounds to assess binding specificity.
Multiple analytical methods should be combined to thoroughly validate protein structural integrity:
| Method | Measures | Resolution Level | Application |
|---|---|---|---|
| Circular dichroism | Secondary structure content | Low | Quick assessment of folding |
| Thermal shift assay | Thermal stability | Low | Buffer optimization |
| Limited proteolysis | Domain organization | Medium | Domain boundary identification |
| Mass spectrometry | Exact mass, modifications | High | Verification of sequence and PTMs |
| Size exclusion chromatography | Oligomeric state, homogeneity | Medium | Aggregation assessment |
| NMR | Tertiary structure, dynamics | Atomic | Detailed structural analysis |
Methodological approach: Begin with basic quality control using SDS-PAGE and size exclusion chromatography to assess purity and homogeneity. Follow with circular dichroism to verify secondary structure content. For detailed characterization, combine limited proteolysis with mass spectrometry. Finally, assess functional activity using binding assays to confirm that the purified protein retains its binding properties.